National failure to operate on early stage pancreatic cancer

被引:472
作者
Bilimoria, Karl Y.
Bentrem, David J.
Ko, Clifford Y.
Stewart, Andrew K.
Winchester, David P.
Talamonti, Mark S.
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA
[2] Amer Coll Surg, Canc Programs, Natl Canc Data Base, Chicago, IL USA
[3] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA
[4] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[5] Evanston NW Healthcare, Dept Surg, Evanston, IL USA
关键词
D O I
10.1097/SLA.0b013e3180691579
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Despite studies demonstrating improved outcomes, pessimism persists regarding the effectiveness of surgery for pancreatic cancer. Our objective was to evaluate utilization of surgery in early stage disease and identify factors predicting failure to undergo surgery. Methods: Using the National Cancer Data Base (1995-2004), 9559 patients were identified with potentially resectable tumors (pretreatment clinical Stage I:T1N0M0 and T2N0M0). Multivariate models were employed to identify factors predicting failure to undergo surgery and assess the impact of pancreatectomy on survival. Results: Of clinical Stage I patients 71.4% (6823/9559) did not undergo surgery; 6.4% (616/9559) were excluded due to comorbidities; 4.2% (403/9559) refused surgery; 9.1% (869/9559) were excluded due to age; and 38.2% (3,644/9559) with potentially resectable cancers were classified as "not offered surgery." Of the 28.6% (2736/9559) of patients who underwent surgery, 96.0% (2630/2736) underwent pancreatectomy, and 4.0% (458/2736) had unresectable tumors. Patients were less likely to undergo surgery if they were older than 65 years, were black, were on Medicare or Medicaid, had pancreatic head lesions, earned lower annual incomes, or had less education (P < 0.0001). Patients were less likely to receive surgery at low-volume and community centers. Patients underwent surgery more frequently at National Cancer Institute/National Comprehensive Cancer Network-designated cancer centers (P < 0.0001). Patients who were not offered surgery had significantly better survival than those with Stage III or IV disease but worse survival than patients who underwent pancreatectomy for Stage I disease (P < 0.0001). Conclusions: This is the first study to characterize the striking under-use of pancreatectomy in the United States. Of early stage pancreatic cancer patients without any identifiable contraindications, 38.2% failed to undergo surgery.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 51 条
  • [1] Adams DB, 2006, J GASTROINTEST SURG, V10, P1223
  • [2] Afsari A, 2002, AM SURGEON, V68, P281
  • [3] American Cancer Society, CANC FACTS FIG
  • [4] [Anonymous], [No title captured]
  • [5] [Anonymous], 2002, AJCC CANC STAGING MA
  • [6] Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort
    Ayanian, JZ
    Zaslavsky, AM
    Fuchs, CS
    Guadagnoli, E
    Creech, CM
    Cress, RD
    O'Connor, LC
    West, DW
    Allen, ME
    Wolf, RE
    Wright, WE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1293 - 1300
  • [7] Trends in the treatment and outcome of pancreatic cancer in the United States
    Baxter, Nancy N.
    Whitson, Bryan A.
    Tuttle, Todd M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) : 1320 - 1326
  • [8] Impact of hospital volume on operative mortality for major cancer surgery
    Begg, CB
    Cramer, LD
    Hoskins, WJ
    Brennan, MF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (20): : 1747 - 1751
  • [9] Determining the quality of breast cancer care: Do tumor registries measure up?
    Bickell, NA
    Chassin, MR
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) : 705 - +
  • [10] BILIMORIA K, 2006, UNPUB